CV2 CARDIOVASCULAR RISK OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS COMPARED TO OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS- AN OBSERVATIONAL STUDY OF A MEDICAID POPULATION
Abstract
Authors
FT Shaya SW Blume CM Blanchette CD Mullins MR Weir